Atara Biotherapeutics Inc (ATRA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.08B
EV to revenue ratio (TTM)
12.64
EV to ebitda
2.21
Financial Performance
Revenue (TTM)
$0.01B
Gross profit (TTM)
$0.00B
EBITDA
-$0.01B
Profitability
Operating margin (TTM)
-627.00%
Profit margin
-269.40%
Return on assets (TTM)
-24.10%
Return on equity (TTM)
-2,015.00%
Per Share Metrics
Revenue per share (TTM)
$0.44
EPS
-$1.30
Diluted EPS (TTM)
-$1.30
Book value
-$3.92
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
14.73
PEG ratio
0
Price to sales ratio (TTM)
13.26
Price to book ratio (TTM)
16.14
Growth
Quarterly earnings growth (YoY)
-96.40%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
0
Buy
2
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.32